Telehealth Weight Loss Program for Breast Cancer Survivors

Running, not enrolling · Not applicable

Conditions studied: Cancer Survivors, Cancer of Breast, Body Weight, Overweight and Obesity

In brief

This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.

Key facts

Study ID

NCT04855552

Run by

Abramson Cancer Center at Penn Medicine

People needed

22

Starts

2021-07-19

Expected to finish

2026-12-01

Last updated by the study team

2026-01-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• History of in situ or invasive breast cancer
• Have completed breast cancer surgery, adjuvant cytotoxic chemotherapy (as indicated) and adjuvant radiation therapy (as indicated) at least 6-months prior to enrollment
• Not on active treatment for other cancer for at least 6-months prior to enrollment
• Currently cancer free
• Overweight or obese (BMI of 25 kg/m\^2 or greater)
• Have internet access and videoconferencing capability

You may not qualify if…

• Current use of weight loss medication (OTC or prescription) or participation in behavioral weight loss program
• Currently participating in a behavioral weight loss program
• Self-report of alcohol or substance abuse within the past 12-months, including at-risk drinking (current consumption of more than 14 drinks per week)
• Undergone bilateral mastectomy
• History of Bulimia nervosa
• Inability to provide informed consent

Where it is running

• University of Pennsylvania (Hospital of the University of Pennsylvania) — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.